# SPD544 High Strength Bioequivalence Study

> **NCT01183234** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 28 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** SPD544
- **DRUG:** Methylphenidate hydrochloride

## Key facts

- **NCT ID:** NCT01183234
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-27
- **Primary completion:** 2010-10-22
- **Final completion:** 2010-10-22
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183234, "SPD544 High Strength Bioequivalence Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01183234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*